Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Scope of the Report:
Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.
The worldwide market for Irritable Bowel Syndrome (IBS) is expected to grow at a CAGR of roughly 16.3% over the next five years, will reach 6530 million US$ in 2024, from 2640 million US$ in 2019, according to a new WMR study.
This report focuses on the Irritable Bowel Syndrome (IBS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
IBS-D Drug
IBS-C Drug
Other

Market Segment by Applications, can be divided into
Women
Men

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Irritable Bowel Syndrome (IBS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Irritable Bowel Syndrome (IBS), with price, sales, revenue and global market share of Irritable Bowel Syndrome (IBS) in 2017 and 2018.
Chapter 3, the Irritable Bowel Syndrome (IBS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Irritable Bowel Syndrome (IBS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Irritable Bowel Syndrome (IBS) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Irritable Bowel Syndrome (IBS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
1.1 Irritable Bowel Syndrome (IBS) Introduction
1.2 Market Analysis by Type
1.2.1 IBS-D Drug
1.2.2 IBS-C Drug
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Women
1.3.2 Men
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Irritable Bowel Syndrome (IBS) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Valeant Pharmaceuticals
2.2.1 Business Overview
2.2.2 Irritable Bowel Syndrome (IBS) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Takeda
2.3.1 Business Overview
2.3.2 Irritable Bowel Syndrome (IBS) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sucampo Pharmaceuticals
2.4.1 Business Overview
2.4.2 Irritable Bowel Syndrome (IBS) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 McNeil Consumer Healthcare
2.5.1 Business Overview
2.5.2 Irritable Bowel Syndrome (IBS) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sebela Pharmaceuticals
2.6.1 Business Overview
2.6.2 Irritable Bowel Syndrome (IBS) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Astellas Pharmaceuticals
2.7.1 Business Overview
2.7.2 Irritable Bowel Syndrome (IBS) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 IM HealthScience
2.8.1 Business Overview
2.8.2 Irritable Bowel Syndrome (IBS) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Irritable Bowel Syndrome (IBS) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Irritable Bowel Syndrome (IBS) Manufacturer Market Share in 2018
3.3.2 Top 6 Irritable Bowel Syndrome (IBS) Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Irritable Bowel Syndrome (IBS) Market Analysis by Regions
4.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Regions
4.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Regions (2014-2019)
4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Regions (2014-2019)
4.2 North America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
4.3 Europe Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
4.5 South America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
5 North America Irritable Bowel Syndrome (IBS) by Country
5.1 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
5.1.1 North America Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
5.1.2 North America Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
5.2 United States Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
5.3 Canada Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
5.4 Mexico Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
6 Europe Irritable Bowel Syndrome (IBS) by Country
6.1 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
6.1.1 Europe Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
6.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
6.2 Germany Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
6.3 UK Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
6.4 France Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
6.5 Russia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
6.6 Italy Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Irritable Bowel Syndrome (IBS) by Country
7.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
7.2 China Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
7.3 Japan Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
7.4 Korea Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
7.5 India Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
8 South America Irritable Bowel Syndrome (IBS) by Country
8.1 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
8.1.1 South America Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
8.1.2 South America Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
8.2 Brazil Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
8.3 Argentina Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
8.4 Colombia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Irritable Bowel Syndrome (IBS) by Countries
9.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
9.3 Turkey Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
9.4 Egypt Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
9.5 Nigeria Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
9.6 South Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
10 Global Irritable Bowel Syndrome (IBS) Market Segment by Type
10.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Type (2014-2019)
10.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2014-2019)
10.2 IBS-D Drug Sales Growth and Price
10.2.1 Global IBS-D Drug Sales Growth (2014-2019)
10.2.2 Global IBS-D Drug Price (2014-2019)
10.3 IBS-C Drug Sales Growth and Price
10.3.1 Global IBS-C Drug Sales Growth (2014-2019)
10.3.2 Global IBS-C Drug Price (2014-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2014-2019)
10.4.2 Global Other Price (2014-2019)
11 Global Irritable Bowel Syndrome (IBS) Market Segment by Application
11.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2014-2019)
11.2 Women Sales Growth (2014-2019)
11.3 Men Sales Growth (2014-2019)
12 Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
12.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2019-2024)
12.2 Irritable Bowel Syndrome (IBS) Market Forecast by Regions (2019-2024)
12.2.1 North America Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
12.2.2 Europe Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
12.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
12.2.4 South America Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
12.2.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
12.3 Irritable Bowel Syndrome (IBS) Market Forecast by Type (2019-2024)
12.3.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2019-2024)
12.3.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2019-2024)
12.4 Irritable Bowel Syndrome (IBS) Market Forecast by Application (2019-2024)
12.4.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2019-2024)
12.4.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Irritable Bowel Syndrome (IBS) Picture
Table Product Specifications of Irritable Bowel Syndrome (IBS)
Figure Global Sales Market Share of Irritable Bowel Syndrome (IBS) by Types in 2018
Table Irritable Bowel Syndrome (IBS) Types for Major Manufacturers
Figure IBS-D Drug Picture
Figure IBS-C Drug Picture
Figure Other Picture
Figure Irritable Bowel Syndrome (IBS) Sales Market Share by Applications in 2018
Figure Women Picture
Figure Men Picture
Figure United States Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure France Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure UK Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure China Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure India Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2014-2024)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Irritable Bowel Syndrome (IBS) Type and Applications
Table Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Irritable Bowel Syndrome (IBS) Type and Applications
Table Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table McNeil Consumer Healthcare Basic Information, Manufacturing Base and Competitors
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Type and Applications
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sebela Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Type and Applications
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table IM HealthScience Basic Information, Manufacturing Base and Competitors
Table IM HealthScience Irritable Bowel Syndrome (IBS) Type and Applications
Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales by Manufacturer (2017-2018)
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2017
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2018
Table Global Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2017-2018)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2017
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2018
Figure Top 3 Irritable Bowel Syndrome (IBS) Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Irritable Bowel Syndrome (IBS) Manufacturer (Revenue) Market Share in 2018
Figure Global Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Sales by Regions (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Regions (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions in 2014
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions in 2018
Figure North America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Europe Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure South America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure North America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table North America Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019)
Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019)
Figure North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2014
Figure North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2018
Table North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
Table North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2014
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2018
Figure United States Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Canada Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Mexico Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table Europe Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019)
Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019)
Table Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2017
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2018
Figure Germany Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure UK Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure France Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Russia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Italy Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries 2018
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries 2018
Figure China Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Japan Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Korea Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure India Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure South America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table South America Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019)
Table South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019)
Figure South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2018
Table South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
Table South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2018
Figure Brazil Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Argentina Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Colombia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2018
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2014
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure UAE Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Egypt Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure Nigeria Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Figure South Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Sales by Type (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Type (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2014-2019)
Figure Global IBS-D Drug Sales Growth (2014-2019)
Figure Global IBS-D Drug Price (2014-2019)
Figure Global IBS-C Drug Sales Growth (2014-2019)
Figure Global IBS-C Drug Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Sales by Application (2014-2019)
Table Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2014-2019)
Figure Global Men Sales Growth (2014-2019)
Figure Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2019-2024)
Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Regions (2019-2024)
Table Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Regions (2019-2024)
Figure North America Sales Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
Figure Europe Sales Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
Figure Asia-Pacific Sales Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
Figure South America Sales Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
Figure Middle East and Africa Sales Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2019-2024)
Table Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2019-2024)
Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2019-2024)
Table Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List

Global Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes), By Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...

Global Polycystic Ovary Syndrome (PCOS) Blood Test Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Polycystic Ovary Syndrome (PCOS) Blood Test Market: The report discusses everything a marketer requires before investing in the global Polycystic Ovary Syndrome (PCOS) Blood Test Market during...

2023-2028 Global and Regional Polycystic Ovary Syndrome Treatment Industry Status and Prospects Professional Market Research Report Standard Version...

The global Polycystic Ovary Syndrome Treatment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market ...

2023-2028 Global and Regional Polycystic Ovary Syndrome (PCOS) Drugs Industry Status and Prospects Professional Market Research Report Standard Version...

The global Polycystic Ovary Syndrome (PCOS) Drugs market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mark...

2023-2028 Global and Regional Thoracic Outlet Syndrome Treatment Industry Status and Prospects Professional Market Research Report Standard Version...

The global Thoracic Outlet Syndrome Treatment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market p...

2023-2028 Global and Regional Polycystic Ovarian Syndrome Treatment Industry Status and Prospects Professional Market Research Report Standard Version...

The global Polycystic Ovarian Syndrome Treatment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help marke...

2023-2028 Global and Regional Cytokine Release Syndrome Treatment Industry Status and Prospects Professional Market Research Report Standard Version...

The global Cytokine Release Syndrome Treatment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market ...

2023-2028 Global and Regional Smith-Magenis Syndrome Treatment Industry Status and Prospects Professional Market Research Report Standard Version...

The global Smith-Magenis Syndrome Treatment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pla...

2023-2028 Global and Regional Metabolic Syndrome Industry Status and Prospects Professional Market Research Report Standard Version...

The global Metabolic Syndrome market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this f...

2023-2028 Global and Regional Polycystic Ovarian Syndrome (PCOS) Therapeutics Industry Status and Prospects Professional Market Research Report Standard Version...

The global Polycystic Ovarian Syndrome (PCOS) Therapeutics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will ...